Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ELA's Ovatio ICDs (implantable cardioverter defibrillators):

This article was originally published in Clinica

Executive Summary

ELA Medical, part of Sorin, has received US FDA market approval for its Ovatio family of dual (DR)- and single-chamber implantable cardioverter defibrillators (ICDs). The Ovatio DR, the firm claims, is the world's smallest dual-chamber ICD, measuring just 29cc. According to Milan, Italy-based Sorin, the 2006 US ICD market is estimated at over $5bn.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT052030

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel